Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06654102 · ClinicalTrials.gov registry record · NA
A Study to Evaluate the Cutaneous Effects of Deep Ultraviolet A +/- High-Energy Visible Blue Light Exposure
A NA study, sponsored by Johnson & Johnson Consumer Inc. (J&JCI).
- Completed
- Registry status
- NA
- Development phase
- 18
- Enrollment target
NCT06654102 is a NA study that has completed, run by Johnson & Johnson Consumer Inc. (J&JCI). The registered enrollment target is 18 participants.
The verdict
NCT06654102, a NA study, has completed, sponsored by Johnson & Johnson Consumer Inc. (J&JCI).
- COMPLETED
- Registry status
- NA
- Development phase
- 18 participants
- Enrollment target
Study Summary
The objective of this study is to assess the level of pigmentation following an acute exposure of skin to light regimens representative of portions of the natural sunlight spectrum and that contain Deep UVA wavelengths with or without HEV Blue Light, as compared to non-irradiated control skin.
Interventions
- OTHER Deep UVA Irradiation
- OTHER Deep UVA+HEV Blue Light Irradiation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18 participants |
| Start Date | 2024-10-23 |
| Est. Completion | 2024-11-26 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06654102
The ClinicalTrials.gov registry entry for NCT06654102 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 18 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Johnson & Johnson Consumer Inc. (J&JCI), which has 40 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Deep UVA Irradiation is the first listed.
NCT06654102 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06654102 about?
NCT06654102 is a clinical study titled "A Study to Evaluate the Cutaneous Effects of Deep Ultraviolet A +/- High-Energy Visible Blue Light Exposure". The objective of this study is to assess the level of pigmentation following an acute exposure of skin to light regimens representative of portions of the natural sunlight spectrum and that contain Deep UVA wavelengths with or without HEV Blue Light, as compared to non-irradiated control skin.
What is the current status of trial NCT06654102?
This trial is currently completed. It is a NA study. The enrollment target is 18 participants. The study started on 2024-10-23. Estimated completion is 2024-11-26.
What interventions are being tested in trial NCT06654102?
The interventions under investigation include: Deep UVA Irradiation (OTHER), Deep UVA+HEV Blue Light Irradiation (OTHER).
Who is sponsoring clinical trial NCT06654102?
This trial is sponsored by Johnson & Johnson Consumer Inc. (J&JCI), which has 40 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.